ARCHIVES

White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns.

This article is from The Cancer Letter archive.

Vol. 31 No. 35 | September 30, 2005

Download PDF Visit The Full Archive

Related Articles

NCAB Committee Urged to Seek Surgical Oncology Certification

June 14, 1985

DeVita Asks Panel For Help On Filling Vacancies, Object To “Effort To Get Us Back To 1970 Level”

November 21, 1980

NCI Has No Intention Of “Dismembering” Groups, Official Says

June 12, 1998

FDA Says ImClone Data Insufficient To Evaluate Colorectal Cancer Drug C225.

January 4, 2002

Two Avastin Trials Show OS Benefit In Advanced Disease

August 27, 2010

NCI Buys Building For PDQ, ICRDB With Donated Money

December 10, 1982